Searched for
MESOBLAST
S&P/ASX 200 hits new 50-day low as Australian shares begin week on soft note: Yancoal Australia Limited climbed, Dyno Nobel saw big fall; check top gainers and losersAustralian shares experienced a significant downturn on Monday, March 9, 2026, with the S&P/ASX 200 index plummeting 2.85% to 8,599.00, mar...- S&P/ASX 200 edges up as Australian shares end flat, energy, gold miners offset bank losses on Middle East conflict; check top gainers and losersThe Australian sharemarket began the week flat. The S&P/ASX 200 index saw minor gains. Miners and energy stocks performed well. Financials ...
- S&P/ASX 200 ends week on a high as Australian shares post best February since 2019; utilities and miners gain, check top gainers and losersAustralian shares finished higher on Friday, February 27, 2026. The S&P/ASX 200 index gained 0.25 percent. Miners saw gains, offsetting dec...
- Australia’s sharemarket begins week on a high: S&P/ASX 200 closes up 0.48%; check top gainers and losers and which were the best-performing sectorsAustralian shares started the week strong on Monday, January 12, 2026. The S&P/ASX 200 index rose, boosted by gains in financials, consumer...
- S&P/ASX 200 finishes slightly higher as Materials and Energy lift the Australian stock market; James Hardie leads gains, Catalyst Metals tops losersThe S&P/ASX 200 index saw a modest rise on Thursday, December 11, climbing 12.60 points to 8,592.00. This uptick pushed the benchmark above...
- Australian Stock Market closes lower: S&P/ASX 200 dips, other key indices also fall, Austal Limited gains, Bapcor falls sharply; check top gainers and losersThe Australian stock market (ASX) closed lower on Tuesday, December 9, 2025, with the ASX 200 dropping 0.45% to 8,585.90, falling below its...
- ASX closes day on positive side: Light & Wonder, Amcor among top gainers, James Hardie tops losers list; check top 5 gainers and losersThe ASX finished Thursday, November 6, 2025, on a high note. The S&P/ASX 200 index saw a gain of 0.30%. Major indices like the S&P/ASX 20, ...
- Australia shares end higher on strong Chinese dataIndustrial output and retail sales in China, Australia's top trading partner, grew at a surprisingly faster pace in October and beat expect...
- Australian shares end at 2-week low as BHP tumbles on ex-div tradeBHP Group, the world's biggest miner, was the top loser on the benchmark with a near 7% tumble, as it traded ex-dividend. It had declared a...
- Australia shares trim losses on better-than-expected GDP dataThe S&P/ASX 200 index closed 0.1% lower at 7,527.1, recovering from a 1% drop earlier in the session, after data showed that Australia's se...
- Tech, healthcare help Australia shares notch 2-week closing highAustralian stocks took cues from solid current account data and an upbeat New York session overnight, Jeffrey Halley, a market analyst at O...
- Novartis signs $50 million deal for Mesoblast cell therapy for COVID and beyondThe Swiss drugmaker's deal with Australia-based Mesoblast secures rights to develop, commercialize and manufacture Remestemcel-L for treati...
- Australia shares snap four-day rally as virus outbreaks weighThe resurgence of the virus globally comes just as travel restrictions are gradually being eased, and it is likely to dampen prospects of a...
- Australia shares rise on lift from financial, energy stocksWall Street gained overnight as U.S. House Speaker Nancy Pelosi expressed hopes of clearing the coronavirus relief package this week, bring...
- Australian shares end over 1% lower after Trump tests positive"The Trump COVID-19 diagnosis is a strong negative for financial markets and will lead to a rotation into defensive positioning," said Jeff...
- Australia shares post 3-week closing highs on banks, iron ore minersLeading the charge, financials rose more than 1%, with the 'big four' banks climbing in a range of 1% to 2.7%.
- Australia shares end higher but posts first weekly loss in AprilThe benchmark S&P/ASX 200 index closed 0.5 per cent higher at 5,242.6. For the week, it shed 4.5 per cent.
- Indian biotech firm Stempeutics Research gets China Patent for its novel stem cell drugStempeutics' stem cell-based drugs enable living tissues to repair or replace tissue or organ function lost due to age, disease, damage or ...
Load More
